655 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Blue Sky Capital Consultants Group Inc.

Blue Sky Capital Consultants Group Inc. acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 655 shares of the medical equipment provider’s stock, valued at approximately $342,000.

A number of other institutional investors also recently added to or reduced their stakes in ISRG. Warm Springs Advisors Inc. acquired a new position in Intuitive Surgical during the fourth quarter worth $991,000. Cache Advisors LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $240,000. GF Fund Management CO. LTD. acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $38,798,000. University of Texas Texas AM Investment Management Co. boosted its position in shares of Intuitive Surgical by 405.5% in the 4th quarter. University of Texas Texas AM Investment Management Co. now owns 2,669 shares of the medical equipment provider’s stock worth $1,393,000 after buying an additional 2,141 shares in the last quarter. Finally, Vega Investment Solutions acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $4,660,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.6%

ISRG stock opened at $539.54 on Friday. The firm has a market cap of $193.38 billion, a PE ratio of 84.17, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1 year low of $396.15 and a 1 year high of $616.00. The company has a fifty day simple moving average of $511.55 and a 200 day simple moving average of $537.84.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter last year, the company posted $1.50 earnings per share. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of the business’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the sale, the chief financial officer now owns 7,162 shares of the company’s stock, valued at $4,060,424.28. The trade was a 2.56% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This trade represents a 60.72% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,700 shares of company stock worth $16,865,621. Insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on ISRG shares. Erste Group Bank cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, CICC Research initiated coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.